Entrepreneur, Investor and New Technology Development and Commercialization Expert
John Engels is a founder and investor focused on new technology development and commercialization. John co-founded AxoGen, a leading medical technology company dedicated to peripheral nerve repair. Prior to AxoGen, he worked at UF, Saffron Hill Ventures and elsewhere on entrepreneurship and venture funding projects. John started his career as an investment banker. He is on the Board of Oxicool, Inc., a privately-held company providing disruptive cooling technologies. He holds a MBA from the Wharton School of Business at UPenn, and a BA from the University of Chicago.